The short-chain fatty acid (SCFA) butyrate, which is produced by the microbial fermentation of dietary fiber in the large intestine, has been shown to have multiple beneficial effects in mammals 4,5,6,7,8,9
Compounded semaglutide may have the same effect as its branded counterparts
The off-label use of GLP-1 agonists for cosmetic weight loss: implications on public health and ethics, 2023
A spokesperson for Novo Nordisk declined to comment Wednesday on where the counterfeit drugs originated and whether they were related to the 2023 warning
1 Andy Morling, head of the MHRAs Criminal Enforcement Unit, called it a landmark result and a major blow to the illegal trade